Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Five Prime Thera
(NQ:
FPRX
)
23.08
USD
-2.63 (-10.23%)
Official Closing Price
Updated: 5:05 PM EST, Feb 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Five Prime Thera
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Today 8:08 EST
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
PTCT
VNDA
VYGR
From
Benzinga
Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
February 22, 2021
Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
From
Business Wire News Releases
Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day
February 05, 2021
Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day
From
Business Wire News Releases
We Did The Math PBE Can Go To $82
January 28, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics?
January 15, 2021
InvestorsObserver issues critical PriceWatch Alerts for OBSV, DBVT, BB, FPRX, and BNGO.
From
PR Newswire
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
EDAP
ITCI
CRIS
From
Benzinga
Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab Plus Chemotherapy as a Frontline Targeted Treatment for FGFR2b+ G
January 15, 2021
Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab Plus Chemo
From
Business Wire News Releases
First Week of January 15th Options Trading For Five Prime Therapeutics (FPRX)
January 13, 2021
Investors in Five Prime Therapeutics, Inc (FPRX) saw new options become available this week, for the January 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Tags
Stocks
From
Market News Video
The Week Ahead In Biotech (Jan. 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
January 09, 2021
After ending 2020 in the green, biotech stocks had a strong start to 2021, partly capitalizing on the broader strength markets saw this past week despite political turmoil at Capitol Hill. The week...
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
January 09, 2021
JPMorgan Chase & Co. CEO Jamie Dimon is to be among the keynote speakers at next week'sJ.P. Morgan Healthcare ...
Tags
Market News
Top Stories
ZLAB
From
Benzinga
Thinking about buying stock in Zomedica, Zosano Pharma, TapImmune, Five Prime Therapeutics, or Inuvo?
January 05, 2021
InvestorsObserver issues critical PriceWatch Alerts for ZOM, ZSAN, MRKR, FPRX, and INUV.
From
PR Newswire
Five Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab at American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Virtual Annual Symposium
December 09, 2020
Five Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab at American Society of Clinical Oncology Gastrointestinal Cancers Annual Symposium
From
Business Wire News Releases
Why Five Prime Therapeutics Stock Gained 312% in November
December 08, 2020
This tiny biotech might be developing a major new cancer drug.
Tags
Market News
FPRX
From
Motley Fool
These Were the 5 Best Cancer Stocks Of 2020
December 07, 2020
Biotech investors had more than just vaccines to think about this year.
Tags
TRIL
MRSN
CRDF
From
Motley Fool
Sum Up The Pieces: PJP Could Be Worth $81
December 07, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Have $1,000? Here Are 3 Top Healthcare Stocks to Buy in December
December 05, 2020
There are plenty of healthcare stocks that have seen share growth this year. Here are three lesser-known stocks that have the potential to continue that growth this month and beyond.
Tags
FLGT
FPRX
WST
From
Motley Fool
Five Prime Announces Closing of Upsized Public Offering of Common Stock
November 17, 2020
Five Prime Announces Closing of Upsized Public Offering of Common Stock
From
Business Wire News Releases
2 Biotech Stocks That Could Double Your Money
November 17, 2020
Aptose Biosciences and Five Prime Therapeutics both have explosive growth potential.
Tags
Market News
APTO
FPRX
From
Motley Fool
TalkMarkets Tuesday Talk: Flying High Where The Geese Soar
November 17, 2020
Amidst the raging pandemic and President Trump’s so far, steadfast reluctance to concede the election to Joe Biden, the stock market continues to fly high seemingly reaching the altitudes of migrating...
Tags
Basic Materials / Commodities
Consumer Goods
Stocks / Equities
From
Blogs - TalkMarkets
A Month for the Ages
November 16, 2020
Just when you think you’ve seen it all from this market, a month like November comes around.
From
Blogs - TalkMarkets
When To Follow Trend
November 16, 2020
Last week was a big one for the market thanks to some critical news from Pfizer Inc. (NYSE: PFE) in the company’s phase 3 COVID-19 ...
Tags
EDRY
General
SOLO
From
Benzinga
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
Biotech stocks advanced in the week ended November 13 amid a vaccine news flow-induced rally that also lifted the broader market. The week started with positive tidings from Pfizer Inc. and its German...
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. The ...
Tags
MYL
PAVM
EDAP
From
Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
AMGN
EIGR
From
Benzinga
65 Biggest Movers From Yesterday
November 13, 2020
Gainers IMAC Holdings, Inc. (NASDAQ: IMAC) shares climbed 83.3% to close at $1.52 on Thursday after the company reported the ...
Tags
JE
SNDL
AHT
From
Benzinga
Five Prime Announces Pricing of Upsized Public Offering of Common Stock
November 12, 2020
Five Prime Therapeutics, Inc. (Nasdaq: FPRX), announced today the pricing of an underwritten public offering of 7,200,000 shares of its common stock at a price to the public of $21.00 per share. The...
From
Business Wire News Releases
12 Healthcare Stocks Moving In Thursday's Intraday Session
November 12, 2020
Gainers IMAC Holdings (NASDAQ:IMAC) stock moved upwards by 87.41% to $1.55 during Thursday's regular session. The ...
Tags
CLSD
CDTX
Movers
From
Benzinga
Mid-Day Market Update: Nasdaq Turns Lower; EuroDry Shares Jump After Q3 Results
November 12, 2020
Midway through trading Thursday, the Dow traded down 0.53% to 29,241.99 while the NASDAQ fell 0.19% to 11,763.76. The S&P also fell, ...
Tags
Intraday Update
Market News
GOCO
From
Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
November 12, 2020
Gainers IMAC Holdings, Inc. (NASDAQ: IMAC) shares jumped 97.9% to $1.64 after the company reported the purchase of Lockwood ...
Tags
Movers
ENR
CDTX
From
Benzinga
Why Five Prime Therapeutics Stock Is Trading Higher Today
November 12, 2020
Five Prime Therapeutics (NASDAQ: FPRX) shares were trading higher on Thursday after the company presented first preclinical data on ...
Tags
Market News
Small Cap
FPRX
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.